Chinese biotech firm WuXi AppTec said to raise $1b in HK share sale

A Wuxi Pharmatech Inc. employee works at one of the production facilities on the outskirts of Shanghai, China, on Friday, Oct. 26, 2007. Photographer: QILAI SHEN/Bloomberg

WuXi AppTec Co., the Shanghai-listed contract medical researcher, has raised $1.01 billion after pricing its Hong Kong first-time share sale above the midpoint of a marketed range, according to people with knowledge of the matter.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Contact us for corporate subscriptions at subs@dealstreetasia.com.